Wintest
6721
Osaka Yuka Industry
4124
D. Western Therapeutics Institute
4576
Asiro
7378
Hamee
3134
(FY)Mar 31, 2024 | (FY)Mar 31, 2023 | (FY)Mar 31, 2022 | (FY)Mar 31, 2021 | (FY)Mar 31, 2020 | (FY)Mar 31, 2019 | (FY)Mar 31, 2018 | (FY)Mar 31, 2017 | (FY)Mar 31, 2016 | (FY)Mar 31, 2015 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating cash flow (Indirect Method) | ||||||||||
Cash from operating activities | 72.73%711.91M | 5.60%412.15M | 38.54%390.28M | -47.10%281.72M | 25.91%532.53M | -16.30%422.96M | -1.04%505.33M | 29.47%510.66M | -50.90%394.41M | 50.39%803.26M |
Net profit before non-cash adjustment | 197.86%355.46M | -43.88%119.34M | -15.97%212.64M | -7.86%253.06M | 35.89%274.64M | -28.28%202.1M | -29.10%281.81M | 32.96%397.46M | 11.74%298.93M | -42.70%267.51M |
Total adjustment of non-cash items | -40.57%193.18M | 71.19%325.05M | 17.89%189.87M | -30.76%161.06M | 19.56%232.61M | 19.09%194.55M | -2.65%163.36M | -14.07%167.8M | -16.11%195.28M | 124.56%232.79M |
-Depreciation and amortization | 15.10%204.81M | 1.93%177.94M | 5.16%174.57M | -12.99%166M | -3.82%190.78M | 21.46%198.37M | -2.41%163.31M | -12.50%167.35M | -16.57%191.26M | 73.10%229.24M |
-Reversal of impairment losses recognized in profit and loss | --0 | --141.74M | --0 | ---- | --43.31M | ---- | ---- | ---- | ---- | ---- |
-Assets reserve and write-off | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 8.88%6.1M | 112.40%5.61M |
-Disposal profit | -65.14%3.54M | -48.20%10.17M | 6,252.10%19.63M | -84.88%309K | 1,222.53%2.04M | -105.67%-182K | 222.64%3.21M | -605.60%-2.62M | 115.10%518K | -114.92%-3.43M |
-Other non-cash items | -216.41%-15.18M | -10.89%-4.8M | 17.69%-4.33M | -49.19%-5.26M | 3.00%-3.52M | -14.97%-3.63M | -202.83%-3.16M | 217.88%3.07M | -289.80%-2.61M | 120.89%1.37M |
Changes in working capital | 606.40%163.27M | -163.54%-32.24M | 90.76%-12.23M | -623.81%-132.39M | -3.92%25.28M | -56.27%26.31M | 210.17%60.16M | 45.28%-54.61M | -132.94%-99.8M | 932.45%302.96M |
-Change in receivables | 89.08%-15.22M | -260.31%-139.37M | 408.56%86.93M | 71.27%17.09M | 138.00%9.98M | -43.27%-26.26M | -121.79%-18.33M | 324.85%84.14M | -169.41%-37.42M | 68.19%-13.89M |
-Change in inventory | 176.82%89.21M | 31.50%-116.14M | -3,621.79%-169.54M | -72.12%4.81M | 185.46%17.26M | 77.34%-20.2M | -303.60%-89.14M | -714.34%-22.09M | -102.99%-2.71M | 402.21%90.57M |
-Change in payables | -63.65%83.99M | 483.89%231.04M | 127.56%39.57M | -2,095.38%-143.6M | -112.78%-6.54M | -70.46%51.2M | 244.43%173.31M | -895.62%-120M | -79.03%15.08M | 69.22%71.94M |
-Change in accrued expense | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -164.73%-86.86M | 395.35%134.19M |
-Provision for loans, leases and other losses | 85.36%-519K | -111.25%-3.55M | 630.68%31.52M | -923.72%-5.94M | -92.63%721K | 40.04%9.79M | 227.61%6.99M | ---5.48M | ---- | ---- |
-Changes in other current assets | 197.54%4.56M | -106.23%-4.67M | -39.04%-2.27M | -207.03%-1.63M | -86.10%1.52M | 339.30%10.95M | -939.77%-4.58M | -105.78%-440K | -68.45%7.61M | 286.82%24.13M |
-Changes in other current liabilities | 186.41%1.24M | -72.00%434K | 149.49%1.55M | -234.54%-3.13M | 177.47%2.33M | 110.36%839K | -187.50%-8.1M | 105.60%9.25M | 213.26%4.5M | -107.49%-3.97M |
Dividends paid (cash flow from operating activities) | ||||||||||
Dividends received (cash flow from operating activities) | ||||||||||
Interest paid (cash flow from operating activities) | -116.43%-3.7M | 10.70%-1.71M | -354.87%-1.92M | 53.53%-421K | 44.72%-906K | 31.48%-1.64M | 22.14%-2.39M | 18.54%-3.07M | 38.09%-3.77M | -6.09M |
Interest received (cash flow from operating activities) | 190.09%18.88M | 4.26%6.51M | 9.68%6.24M | 13.39%5.69M | -7.52%5.02M | -4.46%5.43M | 2.88%5.68M | -17.60%5.52M | 84.55%6.7M | -44.67%3.63M |
Tax refund paid | 4.85%-93.22M | -47.84%-97.97M | 52.16%-66.27M | -99.55%-138.51M | 15.30%-69.41M | 48.62%-81.95M | -12.04%-159.49M | -168.98%-142.35M | 71.53%-52.92M | 7.29%-185.9M |
Other operating cash inflow (outflow) | 0 | 0 | 0 | -1K | 0 | -1K | 0 | 0 | 50.00%-1K | -2K |
Operating cash flow | 98.72%633.87M | -2.85%318.98M | 121.13%328.34M | -68.22%148.48M | 35.51%467.23M | -1.24%344.79M | -5.84%349.12M | 7.65%370.76M | -43.99%344.42M | 80.76%614.9M |
Investing cash flow | ||||||||||
Net PPE purchase and sale | 5.34%-213.94M | -27.53%-226.02M | 48.54%-177.23M | -402.54%-344.42M | 72.65%-68.54M | -131.09%-250.61M | -163.29%-108.45M | 22.16%-41.19M | 85.89%-52.92M | -85.27%-375.09M |
Net intangibles purchase and sale | --0 | --160K | --0 | ---- | ---2.8M | ---- | ---- | ---- | -103.50%-4.71M | 48.58%-2.31M |
Net investment product transactions | ---- | ---- | ---50K | --0 | 195.13%100M | -205.12%-105.12M | --100M | ---- | ---- | ---100M |
Advance cash and loans provided to other parties | 13.04%-1M | 17.86%-1.15M | -62.79%-1.4M | -145.71%-860K | 76.67%-350K | ---1.5M | ---- | 81.43%-260K | 38.05%-1.4M | ---2.26M |
Repayment of advance payments to other parties and cash income from loans | -13.03%1.11M | 51.85%1.27M | 40.30%839K | -23.43%598K | -22.21%781K | 172.09%1M | -80.84%369K | 264.08%1.93M | -19.36%529K | 28.88%656K |
Net changes in other investments | 0.00%-3K | 0.00%-3K | 83.33%-3K | 5.26%-18K | 56.82%-19K | 99.98%-44K | -3,337,000.00%-200.23M | -20.00%-6K | 28.57%-5K | 99.98%-7K |
Investing cash flow | 5.27%-213.83M | -26.93%-225.74M | 48.41%-177.84M | -1,285.46%-344.7M | 108.16%29.08M | -71.03%-356.26M | -426.96%-208.3M | 32.43%-39.53M | 87.79%-58.5M | -97.53%-479.02M |
Financing cash flow | ||||||||||
Net issuance payments of debt | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 |
Net common stock issuance | --0 | ---677.5M | --0 | ---- | ---- | ---- | ---- | ---27K | ---- | ---- |
Increase or decrease of lease financing | -110.15%-43.23M | -5.83%-20.57M | 47.86%-19.44M | 29.88%-37.28M | -1.40%-53.17M | -1.40%-52.44M | -1.39%-51.71M | -1.39%-51M | -1.39%-50.3M | -178.69%-49.62M |
Cash dividends paid | 25.47%-35.9M | -0.13%-48.17M | -0.32%-48.11M | 0.08%-47.95M | 0.07%-47.99M | 0.30%-48.03M | 0.01%-48.17M | 33.28%-48.18M | -50.09%-72.21M | -0.02%-48.11M |
Net other fund-raising expenses | 0.00%-1K | 0.00%-1K | 0.00%-1K | ---1K | ---- | ---1K | ---- | 0.00%-1K | 0.00%-1K | 0.00%-1K |
Financing cash flow | 89.40%-79.13M | -1,004.82%-746.24M | 20.76%-67.54M | 15.74%-85.24M | -0.69%-101.16M | -0.58%-100.46M | -0.68%-99.89M | 19.02%-99.21M | -25.36%-122.51M | -48.17%-97.73M |
Net cash flow | ||||||||||
Beginning cash position | -20.24%2.57B | 2.64%3.23B | -8.22%3.14B | 13.04%3.43B | -3.56%3.03B | 1.32%3.14B | 8.09%3.1B | 6.04%2.87B | 1.43%2.71B | 1.20%2.67B |
Current changes in cash | 152.21%340.9M | -887.20%-652.99M | 129.47%82.95M | -171.23%-281.45M | 453.03%395.15M | -373.43%-111.93M | -82.36%40.94M | 42.00%232.02M | 328.18%163.4M | 20.31%38.16M |
Cash adjustments other than cash changes | ---- | ---- | ---1K | ---- | ---- | ---- | 0.00%-1K | ---1K | ---- | ---- |
End cash Position | 13.25%2.91B | -20.24%2.57B | 2.64%3.23B | -8.22%3.14B | 13.04%3.43B | -3.56%3.03B | 1.32%3.14B | 8.09%3.1B | 6.04%2.87B | 1.43%2.71B |
Free cash flow | 364.90%416.95M | -38.47%89.69M | 173.88%145.76M | -149.97%-197.29M | 327.51%394.81M | -61.36%92.35M | -27.06%239.02M | 14.72%327.71M | 22.56%285.67M | 84.69%233.09M |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |